{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:16:29Z","timestamp":1790770589392,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04697-2","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:32:19Z","timestamp":1784089939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Audiometric changes during teprotumumab therapy for thyroid eye disease: a prospective pilot study"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-9865","authenticated-orcid":false,"given":"Joshua","family":"Van Swol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Spinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Bimali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Burriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addie","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coby","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Donai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"4697_CR1","unstructured":"American Academy of Ophthalmology, Oculofacial Plastic and Orbital Surgery: Basic and Clinical Science Course (American Academy of Ophthalmology, 2020)"},{"issue":"8","key":"4697_CR2","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/bjo.2007.137265","volume":"93","author":"AK Eckstein","year":"2009","unstructured":"A.K. Eckstein, C. Losch, D. Glowacka, M. Schott, K. Mann, J. Esser, N.G. Morgenthaler, Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br. J. Ophthalmol. 93(8), 1052\u20131056 (2009). https:\/\/doi.org\/10.1136\/bjo.2007.137265","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"4697_CR3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41433-024-02967-9","volume":"38","author":"M Moledina","year":"2024","unstructured":"M. Moledina, E.M. Damato, V. Lee, The changing landscape of thyroid eye disease: current clinical advances and future outlook. Eye (Lond). 38(8), 1425\u20131437 (2024). https:\/\/doi.org\/10.1038\/s41433-024-02967-9","journal-title":"Eye (Lond)"},{"issue":"18","key":"4697_CR4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","volume":"376","author":"TJ Smith","year":"2017","unstructured":"T.J. Smith, G.J. Kahaly, D.G. Ezra et al., Teprotumumab for Thyroid-Associated Ophthalmopathy. N Engl. J. Med. 376(18), 1748\u20131761 (2017). https:\/\/doi.org\/10.1056\/NEJMoa1614949","journal-title":"N Engl. J. Med."},{"key":"4697_CR5","doi-asserted-by":"publisher","unstructured":"I. Belinsky, F.X. Jr. Creighton, N. Mahoney et al., Teprotumumab and Hearing Loss: Case Series and Proposal for Audiologic Monitoring. Ophthalmic Plast. Reconstr. Surg. 2022 Jan-Feb 01;38(1):73\u201378. https:\/\/doi.org\/10.1097\/IOP.0000000000001995","DOI":"10.1097\/IOP.0000000000001995"},{"key":"4697_CR6","doi-asserted-by":"publisher","unstructured":"A. Chow, R.Z. Silkiss, Teprotumumab-associated chronic hearing loss screening and proposed treatments. BMJ Case Rep. 15(4) (2022). https:\/\/doi.org\/10.1136\/bcr-2021-248335","DOI":"10.1136\/bcr-2021-248335"},{"issue":"4","key":"4697_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ophtha.2021.10.017","volume":"129","author":"RS Douglas","year":"2022","unstructured":"R.S. Douglas, G.J. Kahaly, S. Ugradar et al., Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study. Ophthalmology. 129(4), 438\u2013449 (2022). https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.017","journal-title":"Ophthalmology"},{"issue":"1","key":"4697_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ophtha.2023.08.001","volume":"131","author":"JA Keen","year":"2024","unstructured":"J.A. Keen, T. Correa, C. Pham, A.D. Claussen, M.R. Hansen, K.D. Carter, E.M. Shriver, Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab. Ophthalmology. 131(1), 30\u201336 (2024). https:\/\/doi.org\/10.1016\/j.ophtha.2023.08.001","journal-title":"Ophthalmology"},{"key":"4697_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2022.02.015","volume":"240","author":"CM Sears","year":"2022","unstructured":"C.M. Sears, A.D. Azad, L. Amarikwa et al., Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease. Am. J. Ophthalmol. 240, 1\u201313 (2022). https:\/\/doi.org\/10.1016\/j.ajo.2022.02.015","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"4697_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/moo.0000000000000652","volume":"28","author":"L Gao","year":"2020","unstructured":"L. Gao, T. Nakagawa, Insulin-like growth factor 1: role in the auditory system and therapeutic potential in otology. Curr. Opin. Otolaryngol. Head Neck Surg. 28(5), 286\u2013290 (2020). https:\/\/doi.org\/10.1097\/moo.0000000000000652","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"issue":"9","key":"4697_CR11","doi-asserted-by":"publisher","first-page":"e654","DOI":"10.1210\/clinem\/dgad213","volume":"108","author":"MN Stan","year":"2023","unstructured":"M.N. Stan, C.C. Krieger, The Adverse Effects Profile of Teprotumumab. J. Clin. Endocrinol. Metab. 108(9), e654\u2013e62 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad213","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4697_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/00003446-199004000-00009","volume":"11","author":"BL Lonsbury-Martin","year":"1990","unstructured":"B.L. Lonsbury-Martin, G.K. Martin, The clinical utility of distortion-product otoacoustic emissions. Ear Hear. 11(2), 144\u2013154 (1990). https:\/\/doi.org\/10.1097\/00003446-199004000-00009","journal-title":"Ear Hear."},{"issue":"6","key":"4697_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/AUD.0b013e318181ad99","volume":"29","author":"KM Reavis","year":"2008","unstructured":"K.M. Reavis, D.S. Phillips, S.A. Fausti et al., Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Ear Hear. 29(6), 875\u2013893 (2008). https:\/\/doi.org\/10.1097\/AUD.0b013e318181ad99","journal-title":"Ear Hear."},{"key":"4697_CR14","doi-asserted-by":"publisher","unstructured":"F. Mahomed, W. Swanepoel de, R.H. Eikelboom, M. Soer, Validity of automated threshold audiometry: a systematic review and meta-analysis. Ear Hear. 34(6), 745\u2013752 (2013 Nov-Dec). https:\/\/doi.org\/10.1097\/01.aud.0000436255.53747.a4","DOI":"10.1097\/01.aud.0000436255.53747.a4"},{"issue":"12","key":"4697_CR15","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1017\/S0022215115002790","volume":"129","author":"N Wooles","year":"2015","unstructured":"N. Wooles, M. Mulheran, P. Bray, M. Brewster, A.R. Banerjee, Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure. J. Laryngol Otol. 129(12), 1174\u20131181 (2015). https:\/\/doi.org\/10.1017\/S0022215115002790","journal-title":"J. Laryngol Otol"},{"issue":"1","key":"4697_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40463-021-00534-w","volume":"50","author":"M Wang","year":"2021","unstructured":"M. Wang, Y. Ai, Y. Han, Z. Fan, P. Shi, H. Wang, Extended high-frequency audiometry in healthy adults with different age groups. J. Otolaryngol. Head Neck Surg. 50(1), 52 (2021). https:\/\/doi.org\/10.1186\/s40463-021-00534-w","journal-title":"J. Otolaryngol. Head Neck Surg."},{"issue":"8","key":"4697_CR17","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1097\/mao.0000000000001134","volume":"37","author":"D Konrad-Martin","year":"2016","unstructured":"D. Konrad-Martin, G.L. Poling, L.E. Dreisbach, K.M. Reavis, G.P. McMillan, J.A. Lapsley Miller, L. Marshall, Serial Monitoring of Otoacoustic Emissions in Clinical Trials. Otol Neurotol. 37(8), e286\u2013e294 (2016). https:\/\/doi.org\/10.1097\/mao.0000000000001134","journal-title":"Otol Neurotol"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04697-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:32:29Z","timestamp":1784089949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04697-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4697"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04697-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"236"}}